Freemont Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-85,300
| Closed | -$4.95M | – | 82 |
|
|
2023
Q3 | $4.95M | Sell |
85,300
-14,400
| -14% | -$836K | 0.74% | 46 |
|
|
2023
Q2 | $6.38M | Hold |
99,700
| – | – | 0.77% | 47 |
|
|
2023
Q1 | $6.91M | Hold |
99,700
| – | – | 0.97% | 34 |
|
|
2022
Q4 | $7.17M | Hold |
99,700
| – | – | 1.13% | 32 |
|
|
2022
Q3 | $7.09M | Sell |
99,700
-2,500
| -2% | -$178K | 1.29% | 26 |
|
|
2022
Q2 | $7.87M | Sell |
102,200
-5,200
| -5% | -$400K | 1.36% | 22 |
|
|
2022
Q1 | $7.84M | Buy |
+107,400
| New | +$7.84M | 1.18% | 27 |
|
|
2021
Q4 | – | Sell |
-154,900
| Closed | -$9.17M | – | 76 |
|
|
2021
Q3 | $9.17M | Buy |
154,900
+600
| +0.4% | +$35.5K | 1.21% | 29 |
|
|
2021
Q2 | $10.3M | Hold |
154,300
| – | – | 1.48% | 21 |
|
|
2021
Q1 | $9.74M | Hold |
154,300
| – | – | 1.59% | 22 |
|
|
2020
Q4 | $9.57M | Buy |
+154,300
| New | +$9.57M | 1.78% | 22 |
|